Literature DB >> 16966600

Extreme genetic risk for type 1A diabetes.

Theresa A Aly1, Akane Ide, Mohamed M Jahromi, Jennifer M Barker, Maria S Fernando, Sunanda R Babu, Liping Yu, Dongmei Miao, Henry A Erlich, Pamela R Fain, Katherine J Barriga, Jill M Norris, Marian J Rewers, George S Eisenbarth.   

Abstract

Type 1A diabetes (T1D) is an autoimmune disorder the risk of which is increased by specific HLA DR/DQ alleles [e.g., DRB1*03-DQB1*0201 (DR3) or DRB1*04-DQB1*0302 (DR4)]. The genotype associated with the highest risk for T1D is the DR3/4-DQ8 (DQ8 is DQA1*0301, DQB1*0302) heterozygous genotype. We determined HLA-DR and -DQ genotypes at birth and analyzed DR3/4-DQ8 siblings of patients with T1D for identical-by-descent HLA haplotype sharing (the number of haplotypes inherited in common between siblings). The children were clinically followed with prospective measurement of anti-islet autoimmunity and for progression to T1D. Risk for islet autoimmunity dramatically increased in DR3/4-DQ8 siblings who shared both HLA haplotypes with their diabetic proband sibling (63% by age 7, and 85% by age 15) compared with siblings who did not share both HLA haplotypes with their diabetic proband sibling (20% by age 15, P < 0.01). 55% sharing both HLA haplotypes developed diabetes by age 12 versus 5% sharing zero or one haplotype (P = 0.03). Despite sharing both HLA haplotypes with their proband, siblings without the HLA DR3/4-DQ8 genotype had only a 25% risk for T1D by age 12. The risk for T1D in the DR3/4-DQ8 siblings sharing both HLA haplotypes with their proband is remarkable for a complex genetic disorder and provides evidence that T1D is inherited with HLA-DR/DQ alleles and additional MHC-linked genes both determining major risk. A subset of siblings at extremely high risk for T1D can now be identified at birth for trials to prevent islet autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966600      PMCID: PMC1563993          DOI: 10.1073/pnas.0606349103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA Class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence.

Authors:  R Hermann; C S Bartsocas; Gy Soltész; A Vazeou; P Paschou; E Bozas; A Malamitsi-Puchner; O Simell; M Knip; J Ilonen
Journal:  Diabetes Metab Res Rev       Date:  2004 Jul-Aug       Impact factor: 4.876

2.  Evidence for HL-A-linked genes in "juvenile" diabetes mellitus.

Authors:  A G Cudworth; J C Woodrow
Journal:  Br Med J       Date:  1975-07-19

3.  Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom.

Authors:  A Paul Lambert; Kathleen M Gillespie; Glenys Thomson; Heather J Cordell; John A Todd; Edwin A M Gale; Polly J Bingley
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

4.  Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).

Authors:  Jennifer M Barker; Katherine J Barriga; Liping Yu; Dongmei Miao; Henry A Erlich; Jill M Norris; George S Eisenbarth; Marian Rewers
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

5.  Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes.

Authors:  Peter Achenbach; Kerstin Koczwara; Annette Knopff; Heike Naserke; Anette-G Ziegler; Ezio Bonifacio
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

6.  A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.

Authors:  Nunzio Bottini; Lucia Musumeci; Andres Alonso; Souad Rahmouni; Konstantina Nika; Masoud Rostamkhani; James MacMurray; Gian Franco Meloni; Paola Lucarelli; Maurizio Pellecchia; George S Eisenbarth; David Comings; Tomas Mustelin
Journal:  Nat Genet       Date:  2004-03-07       Impact factor: 38.330

Review 7.  The genetics of HLA-associated disease.

Authors:  Charles E Larsen; Chester A Alper
Journal:  Curr Opin Immunol       Date:  2004-10       Impact factor: 7.486

8.  Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up.

Authors:  Jennifer M Barker; Stephanie H Goehrig; Katherine Barriga; Michelle Hoffman; Robert Slover; George S Eisenbarth; Jill M Norris; Georgeanna J Klingensmith; Marian Rewers
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

9.  Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to type 1 diabetes in non-obese diabetic mice.

Authors:  K Inoue; H Ikegami; T Fujisawa; S Noso; K Nojima; N Babaya; M Itoi-Babaya; S Makimo; T Ogihara
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

10.  Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus.

Authors:  Deborah Smyth; Jason D Cooper; Joanne E Collins; Joanne M Heward; Jayne A Franklyn; Joanna M M Howson; Adrian Vella; Sarah Nutland; Helen E Rance; Lisa Maier; Bryan J Barratt; Cristian Guja; Constantin Ionescu-Tîrgoviste; David A Savage; David B Dunger; Barry Widmer; David P Strachan; Susan M Ring; Neil Walker; David G Clayton; Rebecca C J Twells; Stephen C L Gough; John A Todd
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

View more
  72 in total

1.  Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complex.

Authors:  Erin E Baschal; Suparna A Sarkar; Theresa A Boyle; Janet C Siebert; Jean M Jasinski; Katharine R Grabek; Taylor K Armstrong; Sunanda R Babu; Pamela R Fain; Andrea K Steck; Marian J Rewers; George S Eisenbarth
Journal:  J Diabetes       Date:  2011-09       Impact factor: 4.006

2.  Novel gene associations in type 1 diabetes.

Authors:  Jorma Ilonen; Robert Hermann
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

3.  Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.

Authors:  Zemin Zhou; Eduardo Reyes-Vargas; Hernando Escobar; Brant Rudd; Alan L Rockwood; Julio C Delgado; Xiao He; Peter E Jensen
Journal:  Eur J Immunol       Date:  2016-01-22       Impact factor: 5.532

4.  Genetic Variation Within the HLA-DRA1 Gene Modulates Susceptibility to Type 1 Diabetes in HLA-DR3 Homozygotes.

Authors:  Özkan Aydemir; Janelle A Noble; Jeffrey A Bailey; Åke Lernmark; Patrick Marsh; Agnes Andersson Svärd; Frank Bearoff; Elizabeth P Blankenhorn; John P Mordes
Journal:  Diabetes       Date:  2019-04-08       Impact factor: 9.461

5.  The next big idea.

Authors:  Marian Rewers
Journal:  Diabetes Technol Ther       Date:  2013-06       Impact factor: 6.118

Review 6.  Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis.

Authors:  Maria J Redondo; Richard A Oram; Andrea K Steck
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

Review 7.  Extreme genetic risk for type 1A diabetes in the post-genome era.

Authors:  Erin E Baschal; George S Eisenbarth
Journal:  J Autoimmun       Date:  2008-05-01       Impact factor: 7.094

8.  MHC fine mapping of human type 1 diabetes using the T1DGC data.

Authors:  C He; S Hamon; D Li; S Barral-Rodriguez; J Ott
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

9.  Three microsatellites from the T1DGC MHC data set show highly significant association with type 1 diabetes, independent of the HLA-DRB1, -DQA1 and -DQB1 genes.

Authors:  M C Eike; K Humphreys; T Becker; M Olsson; B A Lie
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

10.  Single-Cell Analysis of CD4 T Cells in Type 1 Diabetes: From Mouse to Man, How to Perform Mechanistic Studies.

Authors:  Siddhartha Sharma; Jeremy Pettus; Michael Gottschalk; Brian Abe; Peter Gottlieb; Luc Teyton
Journal:  Diabetes       Date:  2019-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.